Peptide Therapeutics intermediate
Milestone 020: Oligopeptide Research Reference
2025: First oral GLP-1 agonist achieves widespread adoption. Transforms diabetes treatment. This peptide or oligopeptide is studied for its biological activi...
By Encyclopeptide Editorial | 1 min read
milestone-020 peptide research
Overview
2025: First oral GLP-1 agonist achieves widespread adoption. Transforms diabetes treatment.
Clinical Significance
This topic has important implications for peptide research and clinical applications.
References
- Encyclopeptide Database. “Milestone 020” monograph. encyclopeptide.com.
Test Your Knowledge
Reinforce what you learned about Milestone 020: Oligopeptide Research Reference with interactive quizzes on Wikipept.
Take a Quiz on Wikipept